These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2253662)

  • 1. Ibopamine-induced reduction of serum prolactin level and milk secretion in puerperal women.
    Nappi C; Colace G; Affinito P; Taglialatela M; Di Renzo GF; Montemagno U; Annunziato L
    Eur J Clin Pharmacol; 1990; 39(2):133-5. PubMed ID: 2253662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary evaluation of the effect of ibopamine on the secretion of prolactin].
    Scarazzati E; Catenazzo G; Melloni CF; Ghirardi P; Bianco L
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1631-5. PubMed ID: 6667307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of prolactin and aldosterone secretion by the dopamine derivative ibopamine.
    Rolandi E; Marchetti G; Franceschini R; Cicchetti V; Gianrossi R; Cantoni V; Barreca T
    Eur J Clin Pharmacol; 1986; 29(5):629-30. PubMed ID: 3956568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ibopamine on peripheral haemodynamics.
    Longhini C; Musacci GF; Ansani L; Toselli T; Artioli M; Bianco L; Ghirardi P
    Eur J Clin Pharmacol; 1983; 24(5):585-9. PubMed ID: 6873134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the orally absorbed dopamine analogue N-methyldopamine diisobutyric ester on plasma prolactin levels.
    Lombardi G; Tommaselli A; Fariello C; Quattrone A; Annunziato L
    Eur J Clin Pharmacol; 1983; 25(1):131-3. PubMed ID: 6617716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects.
    Ferrari C; Barbieri C; Caldara R; Rampini P; Paracchi A; Boghen M; Rauhe WG
    Clin Pharmacol Ther; 1983 Jul; 34(1):74-8. PubMed ID: 6861440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diuretic effects of ibopamine and its action on splanchnic hemodynamics].
    Scardaccio V; Soggia G; Vargiu G; Poddighe P; Manca A; Serra G; Sanna M; Satta A; Faedda R; Bartoli E
    Clin Ter; 1987 Jun; 121(6):495-503. PubMed ID: 2973886
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of dihydroergocryptine on serum prolactin levels and milk secretion in puerperal women.
    Nappi C; Colace G; Di Carlo C; Affinito P; Ruotolo C; Montemagno R; Farace MJ; Mailland F; Di Renzo GF
    Gynecol Endocrinol; 1993 Jun; 7(2):129-33. PubMed ID: 8213227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on the endocrine system of a new dopaminergic agent, ibopamine.
    Soreth JT; Dubb JW; Allison NL; Alexander F; Boden G; Stote RM
    Clin Pharmacol Ther; 1987 Jun; 41(6):627-32. PubMed ID: 3555943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and renal effects of ibopamine in normal subjects.
    Incerti PL; Badalamenti S; Lorenzano E; Graziani G; Morganti A; Salerno F; Ghirardi P
    Arzneimittelforschung; 1986 Feb; 36(2A):405-7. PubMed ID: 3518727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radio-hormonal study (radioimmunoassay) in young women with functional hyperprolactinemia. 2) Effects of a dopaminergic agonist, ibopamine, on the regulation of prolactin and gonadotropin secretion (LH, FSH)].
    Melloni GF; Catenazzo G; Torri A; Fiorenza AM; Melloni R; Scarazatti E
    Boll Soc Ital Biol Sper; 1985 Apr; 61(4):523-30. PubMed ID: 2994694
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C; Triulzi E; Devizzi S; Colombo G; Palvarini M; Pocchiari F; Pataccini R
    Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ibopamine on diuresis in conscious rats in normal and experimentally altered conditions.
    Miragoli G; Ferrini R
    Arzneimittelforschung; 1986 Feb; 36(2A):318-22. PubMed ID: 3707642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of puerperal lactation by oral administration of sulpiride.
    Aono T; Shioji T; Aki T; Hirota K; Nomura A; Kurachi K
    J Clin Endocrinol Metab; 1979 Mar; 48(3):478-82. PubMed ID: 429499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine antagonist domperidone increases prolactin concentration and enhances milk production in dairy cows.
    Lacasse P; Ollier S
    J Dairy Sci; 2015 Nov; 98(11):7856-64. PubMed ID: 26298751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
    Metra M; Missale C; Spano PF; Cas LD
    J Cardiovasc Pharmacol; 1995 May; 25(5):732-40. PubMed ID: 7630152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibopamine.
    Arzneimittelforschung; 1986 Feb; 36(2A):285-407. PubMed ID: 3707639
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
    Melis GB; Gambacciani M; Paoletti AM; Beneventi F; Mais V; Baroldi P; Fioretti P
    J Clin Endocrinol Metab; 1987 Sep; 65(3):541-5. PubMed ID: 3624413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure.
    Andrews R; Charlesworth A; Evans A; Cowley AJ
    Eur Heart J; 1997 May; 18(5):852-7. PubMed ID: 9152656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of ibopamine on central nervous system in mice and rats.
    Ferrini R; Miragoli G; Sala R; Reggiani A
    Arzneimittelforschung; 1986 Feb; 36(2A):327-30. PubMed ID: 3707643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.